The noncompetitive N-methyl-D-aspartate receptor antagonist ketamine produces consistent, rapid, and sustained antidepressant effects in patients suffering from treatment-resistant depression. However, ketamineinduced cognitive impairments remain a major concern. The present study sought to extend the preclinical evaluation of ketamine-induced cognitive impairments by evaluating the dose (1.0-18.0 mg/kg) and time-course (10 min-24 h) of effects of ketamine on sustained attention using a visual signal detection procedure in rats. Overall, ketamine (10.0-18.0 mg/kg) dose-dependently decreased percent hit and correct rejection accuracy. Additionally, these same doses of ketamine increased response latency and trial omissions. In the time-course study, treatment with 18.0 mg/kg ketamine produced the greatest decrease in visual signal detection performance at 10 min, when ketamine decreased percent hit and correct rejection accuracy as well as increased response latency and trial omissions, but returned to saline baseline controls by 100 min. In conclusion, acute ketamine inhibited sustained attention in rats performing a visual signal detection task; however, these effects were short in duration, similar to the short duration (< 2 h) of psychotomimetic effects reported in low-dose ketamine treatment in depressed patients. Behavioural Pharmacology 26:495-499 Copyright
Introduction
On the basis of preclinical and clinical research, the glutamatergic system has emerged as a viable target for the treatment of depression (for a review, see Paul and Skolnick, 2003) . For example, subanesthetic infusions of the noncompetitive N-methyl-D-aspartate (NMDA) receptor antagonist ketamine produce rapid and sustained antidepressant effects in patients suffering from treatmentresistant depression (for a review, see Hillhouse and Porter, 2015) . However, ketamine-induced cognitive impairments remain a major concern. For example, frequent and repeated ketamine users display cognitive deficits across a broad range of cognitive domains, including attention, spatial memory, semantic memory, and working memory (Curran and Morgan, 2000; Morgan et al., 2014) . In healthy volunteers, a subanesthetic infusion of ketamine (0.1-0.8 mg/kg), which is similar to the antidepressant dose of ketamine, was found to produce cognitive impairments during the infusion (Krystal et al., 1994; Morgan et al., 2004a Morgan et al., , 2004b . However, these cognitive impairments were not observed at the 3-day follow-up, and thus, it is possible that chronic ketamine use is needed to produce residual cognitive impairments (Morgan et al., 2004b) . Furthermore, there is limited research, both preclinical and clinical, on the duration of the cognitive deficits produced by acute ketamine.
To address these limitations, the present study evaluated the effects of ketamine on sustained attention, which is a cognitive domain that has been shown to be impaired by repeated ketamine use. To thoroughly address the effects of ketamine on sustained attention, we evaluated the dosedependent and time-dependent effects of ketamine using a visual signal detection procedure in rats. The visual signal detection procedure has been used to assess the effects of antipsychotic drugs, nicotinic agonists, muscarinic antagonists, dopamine reuptake inhibitors, and other NMDA receptor antagonists on sustained attention (Rezvani et al. 2008 (Rezvani et al. , 2009 Levin et al., 2011; Hillhouse and Prus, 2013) .
Methods

Subjects
Fifteen adult male Sprague-Dawley rats (Harlan Laboratories Inc., Frederick, Maryland, USA) weighing between 300 and 350 g at the start of the experiment were used. Rats were housed individually with a 12/12-h light/ dark cycle (lights on 06:00 h). Training and testing sessions were conducted during the light portion of the cycle. After 1 week of acclimation to the vivarium, daily access to food (Teklad LM-485; Harlan Teklad Lab Diets, Harlan, Madison, Wisconsin, USA) was restricted to maintain the rats at 85% of their free feeding body weights; water was freely available in the home cages. All experimental procedures were approved by the Institutional Animal Care and Use Committee at Virginia Commonwealth University and conducted in accordance with National Institutes of Health Guide for the care and use of laboratory animals (Institute of Laboratory Animal Resources, 2011).
Apparatus
Rats were trained and tested in four operant chambers enclosed within a sound attenuating cabinet equipped with a fan for ventilation (Med-Associates Inc., St. Albans, Vermont, USA). Each operant chamber was equipped with a signal (stimulus) light, a houselight, two retractable levers, and a food pellet dispenser. The signal light was located directly above the food receptacle (center of the front panel). The levers were located on either side of the food receptacle. Signal light intensity was adjusted using a fader control (ENV-226A; Med-Associates Inc.) that allowed for four different illumination levels [i.e. background (blank) illumination and three signal intensities], which were calibrated using a light meter (LX1330B; HisGadget, Union City, California, USA). Data were collected using Med PC (version 4.1; Med-Associates Inc.).
Visual signal detection procedure
Rats were trained according to procedures adapted from previously published studies (e.g. Rezvani et al., 2008 Rezvani et al., , 2009 Hillhouse and Prus, 2013) . Lever assignments (i.e. blank and signal lever) were counterbalanced across animals. At the start of each trial, the houselight and signal light were ON and the levers were retracted. The houselight and signal light remained ON at all times, except during 'timeout' periods. Thus, under blank conditions and in-between trials, the background illumination was 0.9 lx. Each trial began with a presignal delay of 3, 6, or 12 s, selected in true random order and presented an equal number of times for each trial type (i.e. blank and each signal intensity). After the presignal delay ended, either a 'blank' or 'signal' occurred for 500 ms. A blank trial consisted of no change in signal light illumination during the 500-ms period. In contrast, a signal trial consisted of an increase in signal light intensity that provided a 0.3, 0.6, and 1.5 lx increase above background illumination for the 500-ms period. Sessions consisted of 90 blank trials and 30 trials for each signal intensity (equaling 90 signal trials). Trial type (i.e. blank and signal) was selected in true random order with no limitations on trial presentation until a trial type met the maximum number of presentations (i.e. 90 blank trials and 30 trials for each signal intensity). After the blank or signal period ended, there was a 1 s delay followed by both levers being extended from the front panel. If a rat pressed the signal lever after a signal occurred, then this was recorded as a 'hit'. If a rat pressed the blank-lever after no signal occurred, then this was recorded as a 'correct rejection'. A correct response (i.e. hit or correct rejection) resulted in the delivery of a food pellet. An incorrect response on a blank or signal trial resulted in a 'timeout' period, in which both the houselight and signal light were turned off resulting in complete darkness for 2 s. If a lever response failed to occur within 5 s, then this was counted as a trial omission and a timeout period occurred. After a lever press or a trial omission, the levers were retracted. The training criteria were met when a rat achieved 70% or greater accuracy on both hits (the highest intensity only) and correct rejections for the overall session for 3 consecutive days. Test sessions occurred twice weekly with at least 2 days separating each test session. A training session was conducted on the day immediately preceding a test session. Test sessions consisted of 180 total trials and were ∼ 30 min in duration. For the dose effect study, ketamine (1.0-18.0 mg/kg, counterbalanced) was administered with a 10 min pretreatment time. After completing a dose-effect curve for a drug, there was a 2 week wash-out period before the time-course effect study was conducted. For more details on training and testing, see Hillhouse and Prus (2013) .
Data analysis
The dependent variables were (i) percent hits; (ii) percent correct rejections; (iii) response latency; and (iv) trial omissions. Percent hits = (number of correct responses on signal trials/the number of signal trials completed) × 100. Percent correct rejections = (number of correct responses on blank trials/the number of blank trials completed) × 100. Response latency = total time elapsed from when the levers were extended to when a lever press occurred/ the number of trials completed (these data were collapsed across signal and blank trials). Response omissions = total number of trials where no response occurred (these data were collapsed across signal and blank trials). All data are reported as means SEM. A two-factor repeated measures analysis of variance (ANOVA) was conducted using signal intensity and drug dose or time as factors for percent hits. A one-way repeated measures ANOVA was used to assess the effect of drug dose or time on percent correct rejections, response latency, or trial omissions. A significant ANOVA was followed by a Holm-Sidak post-hoc test, and criterion for significance was set at P value less than 0.05. All statistical analyses were conducted using GraphPad Prism 6.0 (GraphPad, La Jolla, California, USA) for Windows.
Drugs
Ketamine HCl (Sigma Aldrich, St. Louis, Missouri, USA) was dissolved in 0.9% physiological saline, and was administered intraperitoneally at a volume of 1.0 ml/kg. Doses and pretreatment times were based on previous studies in the literature (Páleníček et al., 2011; Koike et al., 2013; Hillhouse and Porter, 2014; Hillhouse et al., 2014a Hillhouse et al., , 2014b ). Figure 1 shows the dose-effects of ketamine on percent hits (a) and percent correct rejections (b). Ketamine produced mixed effects across the three light intensities: significant main effect of dose [F(4, 56) = 4.74, P < 0.01], signal intensity [F(2, 28) = 225.3, P < 0.001], and interaction [F(8, 112) = 13.02, P < 0.001]. Compared with saline, 3.2, 10.0, and 18.0 mg/kg ketamine significantly increased percent hits at the lowest signal intensity. The 18.0 mg/kg dose of ketamine significantly decreased percent hits at the intermediate signal intensity and the 10.0 and 18.0 mg/kg doses decreased percent hits at the highest signal intensity (Fig. 1a ). Ketamine produced a dose-dependent decrease in percent correct rejections [F(4, 56) = 15.93, P < 0.001; Fig. 1b ]. Ketamine dose-dependently increased mean response latency [F(4, 56) = 48.20, P < 0.001] and trial omissions [F(4, 56) = 7.87, P < 0.001] (Table 1 ). Compared with saline baseline, 18.0 mg/kg ketamine did not significantly alter percent hits at the lowest or intermediate signal intensities at any time points; however, 18.0 mg/kg ketamine significantly decreased percent hits at the highest signal intensity at 10 and 30 min (Fig. 1c) . Ketamine decreased percent correct rejections only at 10 min [F(4, 56) = 14.63, P < 0.001; Fig. 1d ]. Treatment with 18.0 mg/kg ketamine increased mean response latency [F(4, 56) = 80.29, P < 0.001] and trial omissions [F(4, 56) = 53.31, P < 0.001] only at 10 min (Table 1 ). The increase in response Effects of ketamine on signal detection performance Hillhouse et al. 497 latencies and trial omissions in the time-course study as compared with the initial dose-effect curve can be attributed to the wash-out period between these procedures. A number of the rats appeared to have lost tolerance to the rate-suppressant effects of ketamine that had developed during the dose-response curve and their data account for the increases. The rate-suppressant effects of ketamine and development of tolerance to ratesuppressant effects has been shown previously in other studies (Negus et al., 1993; Gilmour et al., 2009; Smith et al., 2011; Hillhouse et al., 2014b) .
Results
Discussion
The visual signal detection procedure was used to evaluate the dose and time-course of effects of ketamine on sustained attention in rats. There were two main findings. First, ketamine (10.0-18.0 mg/kg) decreased signal detection performance at doses that have been shown to produce antidepressant-like effects in rats (Réus et al., 2011; Koike et al., 2013; Hillhouse et al., 2014a Hillhouse et al., , 2014b Zhou et al., 2014) . The effects of ketamine in the present study are consistent with the effects of the noncompetitive NMDA receptor antagonist MK-801, which also produces a decrease in percent hit and correct rejection accuracy and increase in response latency and trial omissions (Rezvani et al., 2009 ). The impairments produced by ketamine in the signal detection task parallel findings in other attention tasks. For example, acute and repeated ketamine administration produced cognitive impairments in the attentional set-shift and fivechoice serial reaction time tasks (Nikiforuk et al., 2010 (Nikiforuk et al., , 2013 Smith et al., 2011; Nikiforuk and Popik, 2014) . However, Nikiforuk and Popik (2014) found that ketamine reversed stress-induced deficits in the attentional set-shifting task, which suggests that ketamine may have procognitive effects in stressed individuals.
The second main finding was that the time-course of effects following treatment with 18.0 mg/kg ketamine was short, which coincides with the pharmacokinetics of ketamine in the rat brain (Páleníček et al., 2011) . In the present study, the cognitive-disrupting effects of ketamine (18.0 mg/kg) peaked at 10 min and returned to saline baseline controls by 100 min. Páleníček et al. (2011) found that ketamine concentrations peak in rat brain between 10 and 20 min following intraperitoneal administration and is completely eliminated from rat brain by 120 min. The behavioral effects from the present study also are consistent with clinical research. For example, both patients with treatment-resistant depression and healthy volunteers display ketamine-induced cognitive impairments following ketamine infusions, but these dissipate relatively quickly (Morgan et al., 2004b; Murrough et al., 2014) .
In conclusion, acute ketamine produced a brief decrease in sustained attention in rats performing the visual signal detection task. While ketamine does disrupt cognitive functioning in both rodents and humans, these effects are short in duration as compared with its antidepressant effects, which have been shown to last longer than a week. Further, Murrough et al. (2014) suggest that the degree of ketamine-induced cognitive effects may be predictive of antidepressant effects, such that greater cognitive impairments are predictive of a decreased antidepressant response in treatment-resistant patients. 
